Starpharma Holdings (Starpharma Holdings) Long-Term Debt : $1.58 Mil (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Starpharma Holdings Long-Term Debt?

Starpharma Holdings's Long-Term Debt for the quarter that ended in Dec. 2023 was $1.58 Mil.

Starpharma Holdings's quarterly Long-Term Debt declined from Dec. 2022 ($2.11 Mil) to Jun. 2023 ($0.00 Mil) but then increased from Jun. 2023 ($0.00 Mil) to Dec. 2023 ($1.58 Mil).

Starpharma Holdings's annual Long-Term Debt increased from Jun. 2021 ($0.00 Mil) to Jun. 2022 ($2.81 Mil) but then declined from Jun. 2022 ($2.81 Mil) to Jun. 2023 ($0.00 Mil).

Starpharma Holdings Long-Term Debt Historical Data

The historical data trend for Starpharma Holdings's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Starpharma Holdings Long-Term Debt Chart

Starpharma Holdings Annual Data

Trend

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Long-Term Debt

Get a 7-Day Free Trial

2.81

Starpharma Holdings Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Long-Term Debt	Get a 7-Day Free Trial															2.08	2.81	2.11	-	1.58

Starpharma Holdings (OTCPK:SPHRY) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

Starpharma Holdings Long-Term Debt Related Terms

Thank you for viewing the detailed overview of Starpharma Holdings's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Starpharma Holdings (Starpharma Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Starpharma Holdings Ltd (OTCPK:SPHRY) » Definitions » Long-Term Debt

Comparable Companies

Traded in Other Exchanges

SPHRF:USA PQ6:Germany SPL:Australia

Address

4-6 Southampton Crescent, Abbotsford, Melbourne, VIC, AUS, 3067

Website

https://www.starpharma.com

Starpharma Holdings Ltd is an Australia-based company engaged in the research, development, and commercialization of dendrimer products for pharmaceutical, life science, and other applications. It focuses on the development of VivaGel for the management and prevention of bacterial vaginosis and as a condom coating and VIRALEZE an antiviral nasal spray.